PAULA CHARBONNET: Open Payments
NPI 1467063651 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 55 payments from 16 companies in 2025. Trend: 2023 $1,345 · 2024 $399 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $396 |
| ABBVIE INC. | 13 | $351 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $128 |
| LEO Pharma Inc. | 4 | $109 |
| PFIZER INC. | 3 | $66 |
| GENZYME CORPORATION | 2 | $66 |
| UCB, Inc. | 2 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Amgen Inc. | 2 | $45 |
Products named: NEMLUVIO, RINVOQ, SKYRIZI, ILUMYA, CIBINQO, DUPIXENT, Bimzelx, LIBTAYO.
Industry payments across GA — which companies pay providers there.
